AlphaCentric Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
2024
Q3
$1.27M Hold
2024
Q2
$630K Hold
2024
Q1
$1.21M Buy
2023
Q4
$1.93M Buy
2023
Q3
$2.18M Buy
2021
Q4
$1.06M Buy
2021
Q3
$181K Hold
2021
Q2
$193K Hold
2021
Q1
$182K Buy
2020
Q4
$71K Buy